TannazArmaghanyMD

Oncology • Houston, TX

Gastrointestinal Cancer, Hematologic Oncology

Assistant Professor

Join to view full profile

Dr. Armaghany is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Armaghany's full profile

Already have an account?

Office
Baylor McNair medical center
7200 Cambridge st
Houston, TX 77030
Phone+1 713-798-3750
Is this information wrong?

Summary

Dr. Tannaz Armaghany is an hematologits and medical oncologist in Houston, TX and is affiliated with Baylor St. Luke's Medical Center and Harris Health System. She specializes in gastrointestinal cancers and is the chair of the liver cancer working group of Dan Duncan Comprehensive Cancer center of Baylor in Houston. She is the primary investigator of multiple clinical trials including CAR- T cell in hepatocellular carcinoma.

Education & Training

Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2002 - 2005
Azad UniversityClass of 1999

Certifications & Licensure

TX State Medical License 2013 - 2025
LA State Medical License 2005 - 2016

Clinical Trials

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients Start of enrollment: 2010 Dec 01
Completed
Phase 1, Phase 2
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer Start of enrollment: 2014 Apr 01
Recruiting
Phase 3

Publications & Presentations

PubMed

Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
David Steffin, Nisha Ghatwai, Antonino Montalbano, Purva Rathi, Amy N Courtney, Azlann B Arnett, Julien Fleurence, Ramy Sweidan, Thao Wang, Huimin Zhang, Prakash Masan...> ;Research Square. 2024 Apr 3
1 citations
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
Rikita I Hatia, Madhulika Eluri, Ernest T Hawk, Akram Shalaby, Elif Karatas, Ahmed Shalaby, Ahmed Abdelhakeem, Reham Abdel-Wahab, Ping Chang, Asif Rashid, Prasun K Jal...> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Oct 2
6 citations
Solitary Brain Metastasis in a Patient With Ovarian Cancer With BRCA2 Mutation
Katherine Root, Tannaz Armaghany> ;Journal of Clinical Oncology. 2012 Sep 1
228 citations
Genetic alterations in colorectal cancer.
Tannaz Armaghany, Jon D Wilson, Quyen D. Chu, Glenn Mills> ;Gastrointestinal Cancer Research. 2012 Jan 1
Effect of insurance status and distance from treatment center on the overall survival of patients with non-small cell lung caner treated in an academic center.
Armaghany T, Mills G, Shi R, Runhua S, Ataei H> ;J. Clin. Oncol.. 2009-05-20
The relation of obesity, body surface area, race and sex with chemotherapy associated toxicity.
Armaghany T, McLarty J, Marion J> ;J. Clin. Oncol.. 2008-05-20
Join now to see all

Hospital Affiliations

St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Harris Health SystemHouston, Texas